Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study-Reference-Cited by-同舟云学术

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study

Published:2011-05 Issue:5 Volume:10 Page:424-435
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Barthel Henryk,Gertz Hermann-Josef,Dresel Stefan,Peters Oliver,Bartenstein Peter,Buerger Katharina,Hiemeyer Florian,Wittemer-Rump Sabine M,Seibyl John,Reininger Cornelia,Sabri Osama

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference37 articles.

1. Neuropathological stageing of Alzheimer-related changes;Braak;Acta Neuropathol,1991

2. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide;Haass;Nat Rev Mol Cell Biol,2007

3. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria;Dubois;Lancet Neurol,2007

4. Revising the definition of Alzheimer's disease: a new lexicon;Dubois;Lancet Neurol,2010

5. Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment;Lorenzi;Neurobiol Aging,2010

Cited by 505 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcopenia is a predictor for Alzheimer’s continuum and related clinical outcomes;Scientific Reports;2024-09-10

2. Binding adaptability of chemical ligands to polymorphic α-synuclein amyloid fibrils;Proceedings of the National Academy of Sciences;2024-08-22

3. Effects of strategic white matter hyperintensities of cholinergic pathways on basal forebrain volume in patients with amyloid-negative neurocognitive disorders;Alzheimer's Research & Therapy;2024-08-15

4. Novel β-amyloid PET Imaging Study of [¹⁸F]92 in Patients with Cognitive Decline;ACS Omega;2024-08-01

5. Association of liver function markers and apolipoprotein E ε4 with pathogenesis and cognitive decline in Alzheimer’s disease;Frontiers in Aging Neuroscience;2024-07-24